Clinical trial
Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in…
NCT00107016 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00107016 |
|---|---|
| Title | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women |
| Official title | A Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Study Assessing the Value of Adding Everolimus to Letrozole as Preoperative Therapy of Primary Breast Cancer in Postmenopausal Women |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasm |
| Intervention type | Drug |
| Interventions | RAD001, Letrozole 2.5mg |
| Enrollment | 267 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Apr 5, 2005 |
| Last update posted | Mar 4, 2013 |
| Countries | Austria, Belgium, Canada, France, Germany, Italy, Russia, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: